ETF Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/18/2026 | CALL | $145.00 | 5,032 | +5,000 | +15,625.00% |
| 12/18/2026 | CALL | $115.00 | 2,989 | +2,345 | +364.13% |
| 01/16/2026 | PUT | $101.00 | 3,002 | +999 | +49.88% |
| 11/21/2025 | CALL | $115.00 | 14,092 | +656 | +4.88% |
| 11/21/2025 | PUT | $95.00 | 14,090 | +461 | +3.38% |
| 10/31/2025 | CALL | $111.00 | 520 | +342 | +192.13% |
| 01/15/2027 | CALL | $105.00 | 72 | -44 | -37.93% |
| 12/19/2025 | CALL | $109.00 | 227 | -101 | -30.79% |
| 10/24/2025 | PUT | $107.00 | 1,912 | -102 | -5.06% |
| 01/16/2026 | CALL | $135.00 | 11,015 | -300 | -2.65% |
| 11/21/2025 | CALL | $112.00 | 1,319 | -376 | -22.18% |
| 10/31/2025 | PUT | $104.00 | 5,028 | -4,112 | -44.99% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Is It Time to Buy Biotech Stocks?
08/06 04:28 pm
The Motley Fool
Read more'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds
01/17 11:35 am
Benzinga
Read more2 Biotech Stocks to Buy Hand Over Fist in December
12/07 09:45 am
The Motley Fool
Read moreIs Biotech’s Bull Run Over? Examining Election Impacts
11/22 08:29 am
Investing.com
Read more8 Charts Suggesting Stock Market Pullback Could Deepen in the Near-Term
10/08 02:40 am
Investing.com
Read moreShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
08/06 06:20 am
Zacks Investment Research
Read moreLife May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
07/29 09:37 am
The Motley Fool
Read moreTop Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
07/01 01:38 pm
Benzinga
Read moreIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
06/25 06:20 am
Zacks Investment Research
Read moreShould You Invest in the VanEck Biotech ETF (BBH)?
06/17 06:20 am
Zacks Investment Research
Read moreSoft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
06/12 10:09 am
Benzinga
Read moreIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
06/11 06:20 am
Zacks Investment Research
Read moreShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
06/04 06:20 am
Zacks Investment Research
Read moreShould You Invest in the SPDR S&P Biotech ETF (XBI)?
05/30 06:20 am
Zacks Investment Research
Read moreShould You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
05/13 06:20 am
Zacks Investment Research
Read moreIs Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
05/10 06:20 am
Zacks Investment Research
Read moreIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
04/23 06:20 am
Zacks Investment Research
Read moreSome Bubbles Are Starting To Pop
04/21 10:49 am
Seeking Alpha
Read moreShould You Invest in the VanEck Biotech ETF (BBH)?
04/15 06:20 am
Zacks Investment Research
Read moreIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
04/09 06:20 am
Zacks Investment Research
Read moreShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
04/01 06:20 am
Zacks Investment Research
Read more3 Top ETFs I Plan to Buy in April
03/31 05:49 am
The Motley Fool
Read more2 Top Biotech Buyout Candidates
03/28 01:55 pm
Zacks Investment Research
Read moreShould You Invest in the SPDR S&P Biotech ETF (XBI)?
03/25 06:20 am
Zacks Investment Research
Read moreGeron’s stock soars 95% after FDA advisory panel votes in favor of blood-disorder drug
03/15 11:50 am
MarketWatch
Read moreShould You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
03/13 06:20 am
Zacks Investment Research
Read moreIs Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
03/05 07:20 am
Zacks Investment Research
Read moreMarkets May Be Ripe for a Pullback But Long-Term Bullish View Remains Intact
03/05 03:08 am
Investing.com
Read moreLABU: A Really Bad Drift
03/03 03:12 am
Seeking Alpha
Read moreThis biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag
02/29 07:46 pm
MarketWatch
Read moreBiotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
02/28 01:51 pm
Benzinga
Read moreOpportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
02/28 01:19 pm
Benzinga
Read moreIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
02/22 07:20 am
Zacks Investment Research
Read moreWhere Are Biotech ETFs Headed After Q4 Earnings?
02/14 05:47 pm
Zacks Investment Research
Read moreShould You Invest in the VanEck Biotech ETF (BBH)?
02/12 07:20 am
Zacks Investment Research
Read moreIs First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
02/05 07:20 am
Zacks Investment Research
Read moreShould You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
01/30 07:20 am
Zacks Investment Research
Read moreTHQ Vs. XBI: Keeping The Biotech ETF For Now
01/28 02:00 am
Seeking Alpha
Read moreShould You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
01/09 05:54 pm
Zacks Investment Research
Read moreBiotech ETFs Stage Solid Comeback at the Start of 2024
01/09 12:05 pm
Zacks Investment Research
Read moreWall Street Thinks These 2 Biotech Stocks Could Soar in 2024
01/03 02:15 pm
The Motley Fool
Read moreIs Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
01/03 07:20 am
Zacks Investment Research
Read more3 Thematic Growth ETFs to Load Up on Right Now
12/30 11:30 am
The Motley Fool
Read more